p/a
On $p$-soluble groups with a generalized $p$-central or powerful Sylow $p$-subgroup
7
Resonance production in p+p, p+A and A+A collisions measured with HADES
8
P. A.
5
<p>Alkaptonuria: Current Perspectives</p>
11
<p>Accountability in patient adherence</p>
7
On the rate of convergence of ((||ƒ||p)¦(||ƒ||∞))p as p →∞
10
<p>Unmet needs in asthma</p>
13
A&P
9
P< .001), total cholesterol ( P= .02), LDL ( P= .04), triglycerides ( P= .02), HOMA ( P= .04), and VAI P= .04), and fewer diagnostic criteria for the Metabolic Syndrome (
13
On p p rings which are reduced
5
CLF Ethics, Economics, and Policy.pptx
74
<p>Refractory Sarcoidosis: A Review</p>
23
Exploring the spin states of 90Zr populated by (p,p’), (p,d), and (p,t) reactions
12
<p>Matrix Stiffness and Colorectal Cancer</p>
9
<p>Oral microbiota and gastrointestinal cancer</p>
8
<p>Tapentadol: an overview of the safety profile</p>
8
<p>Psoriasis and alcohol</p>
5
All the Solutions of the Diophantine Equations $p^x + p^y = z^2$ and $p^x - p^y = z^2$ when p≥2 is Prime
9
<p>Omadacycline: a novel aminomethylcycline</p>
21
|P| ) time where |P| is
6